Browse Pet Safety Reports
143,870 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 143,870 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 143,870 FDA veterinary adverse event reports for Cat.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Sep 2, 2025 | Cat | Cat (unknown) | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS | Outcome Unknown |
| Sep 2, 2025 | Cat | Cat (unknown) | Lotilaner | Licking; Tongue disorder NOS; Fever | Recovered/Normal |
| Sep 2, 2025 | Cat | Cat (unknown) | Bexagliflozin | Ketosis | Ongoing |
| Sep 2, 2025 | Cat | Domestic Shorthair | Buprenorphine | Dysphoria | Recovered/Normal |
| Sep 2, 2025 | Cat | Domestic Longhair | Eprinomectin; Praziquantel; Esafoxolaner | Application site residue; Application site hair loss | Outcome Unknown |
| Sep 2, 2025 | Cat | Persian | Selamectin;Sarolaner | Emesis (multiple); Lethargy (see also Central nervous system depression in Ne... | Ongoing |
| Sep 2, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Head bobbing; Ataxia; Abnormal posture NOS | Outcome Unknown |
| Sep 2, 2025 | Cat | Cat (other) | Oclacitinib Maleate | Accidental exposure; Death | Died |
| Sep 2, 2025 | Cat | Domestic Shorthair | Tiletamine Hcl;Zolazapam Hcl | Anaphylaxis; Staggering | Ongoing |
| Sep 2, 2025 | Cat | Domestic Shorthair | Fluralaner/Moxidectin Spot-On | Facial paralysis | Recovered/Normal |
| Sep 2, 2025 | Cat | Cat (unknown) | Fluralaner/Moxidectin Spot-On | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Sep 2, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Emesis (multiple) | Recovered/Normal |
| Sep 2, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Lethargy (see also Central nervous system depression in Neurological); Vomiti... | Outcome Unknown |
| Sep 2, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Wobbliness; Drooling | Outcome Unknown |
| Sep 2, 2025 | Cat | Maine Coon | Eprinomectin; Praziquantel; Esafoxolaner | Lack of efficacy (endoparasite) - roundworm NOS | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Mediumhair | Bexagliflozin | Elevated betahydroxybutyrate (BHBA); Weight loss; Loss of condition score; Hy... | Ongoing |
| Sep 1, 2025 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Aggression; Urinary tract disorder NOS | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Foaming at the mouth; Pain NOS | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS; Leucocytosis NOS; Neutrophilia; Diarrhoea; Ketosis; A... | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Longhair | Eprinomectin; Praziquantel; Esafoxolaner | Anxiety; Hyperactivity; Self trauma | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Diarrhoea; Lack of efficacy - NOS; Weight loss; Heart murmur; Ketosis; Elevat... | Ongoing |
| Sep 1, 2025 | Cat | Domestic Mediumhair | Bexagliflozin | Hypercalcaemia | Ongoing |
| Sep 1, 2025 | Cat | Cat (unknown) | Trilostane | Accidental exposure; Not himself/herself; Off colour; Behavioural disorder NO... | Outcome Unknown |
| Sep 1, 2025 | Cat | Cat (other) | Frunevetmab | Dermatitis | Recovered/Normal |
| Sep 1, 2025 | Cat | Cat (unknown) | Buprenorphine | Pale mucous membrane; Neurological disorder NOS | Recovered/Normal |
| Sep 1, 2025 | Cat | Domestic Shorthair | Molidustat Sodium | Lack of efficacy - NOS; Lethargy (see also Central nervous system depression ... | Ongoing |
| Sep 1, 2025 | Cat | Domestic Shorthair | Mirtazapine | Ocular discharge; Application site crust | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Mediumhair | Selamectin;Sarolaner | Intentional misuse; Lack of efficacy - NOS; Weight loss; Lymphocytosis | Ongoing |
| Sep 1, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Lethargy (see also Central nervous system depression in Neurological); Appeti... | Recovered/Normal |
| Sep 1, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Polyuria; Polydipsia; Inappetence; Not himself/herself; Inappropriate defecat... | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Diarrhoea; Ketonuria | Outcome Unknown |
| Sep 1, 2025 | Cat | Cat (unknown) | Pentobarbital Sodium, Phenytoin Sodium | Lack of efficacy - NOS; Death by euthanasia | Euthanized |
| Sep 1, 2025 | Cat | Bengal | Bexagliflozin | Soft stool; Ketosis | Ongoing |
| Sep 1, 2025 | Cat | Domestic Shorthair | Mirtazapine | Ataxia; Neurological signs NOS; Ear infection NOS | Recovered/Normal |
| Sep 1, 2025 | Cat | Cat (other) | Selamectin;Sarolaner | Application site alopecia | Ongoing |
| Sep 1, 2025 | Cat | Domestic Shorthair | Selamectin | Lack of efficacy (ectoparasite) - flea; Underfilling, Tubes; Underfilling, Tubes | Outcome Unknown |
| Sep 1, 2025 | Cat | Maine Coon | Selamectin;Sarolaner | Application site hair loss; Application site pruritus; Application site self ... | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Other abnormal test result NOS | Recovered/Normal |
| Sep 1, 2025 | Cat | Domestic Longhair | Fluralaner/Moxidectin Spot-On | Lack of efficacy (ectoparasite) - flea; Drug administered at inappropriate site | Ongoing |
| Sep 1, 2025 | Cat | Cat (unknown) | Velagliflozin Proline Monohydrate | Foaming at the mouth; Vomiting; Urinary tract infection | Outcome Unknown |
| Sep 1, 2025 | Cat | Domestic Longhair | Oclacitinib Maleate | Decreased haematocrit; Elevated blood urea nitrogen (BUN); Hyperkalaemia; Qui... | Ongoing |
| Sep 1, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Lethargy (see also Central nervous system depression in Neurological); Anorex... | Outcome Unknown |
| Sep 1, 2025 | Cat | Cat (unknown) | Imidacloprid; Moxidectin | Localised itching; Rubbing; Skin discolouration NOS; Skin lesion NOS; Skin so... | Outcome Unknown |
| Sep 1, 2025 | Cat | Cat (unknown) | Mirtazapine | Behavioural disorder NOS | Recovered/Normal |
| Sep 1, 2025 | Cat | Maine Coon | Selamectin;Sarolaner | Application site hair loss; Application site burn | Ongoing |
| Aug 31, 2025 | Cat | Cat (other) | Selamectin;Sarolaner | Hiding; Application site burn; Application site pain; Application site hair c... | Recovered/Normal |
| Aug 31, 2025 | Cat | Crossbred Feline/cat | Nitenpyram | Hyperactivity; Crying; Shaking; Dilated pupils | Recovered/Normal |
| Aug 31, 2025 | Cat | Domestic Shorthair | Frunevetmab | Urinary tract infection; Anaemia NOS; Ataxia | Ongoing |
| Aug 31, 2025 | Cat | Cat (unknown) | Velagliflozin Proline Monohydrate | Diarrhoea | Outcome Unknown |
| Aug 31, 2025 | Cat | Siamese, Cat (other) | Frunevetmab | Anorexia; Oral mass; Oral bleeding; Intentional misuse | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.